Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90024


Purpose:

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.


Study summary:

To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.


Criteria:

Inclusion Criteria: - Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence; non-treatment seeking individuals - Be able to verbalize understanding of consent form; provide written informed consent Exclusion Criteria: - Please contact site for more information


NCT ID:

NCT00033072


Primary Contact:

Principal Investigator
Thomas Newton, M.D.
University of California, Los Angeles


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90024
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.